Literature DB >> 10094839

Receptor-type protein-tyrosine phosphatase mu is expressed in specific vascular endothelial beds in vivo.

C Bianchi1, F W Sellke, R L Del Vecchio, N K Tonks, B G Neel.   

Abstract

We investigated the localization of receptor-type protein-tyrosine phosphatase mu (RPTPmu) in tissues by immunofluorescence. RPTPmu immunoreactivity was found almost exclusively within vascular endothelial cells. RPTPmu was more abundant in the arterial tree than in the venous circulation. This pattern of expression was opposite to that of the von Willebrand factor and demonstrated a lack of difference in expression of VE-cadherin. RPTPmu was undetectable in the endocardium. In agreement with previous work on nonendothelial cell lines, RPTPmu was exclusively at the lateral aspects of endothelial cells in vivo and at cell-cell contacts as well as ex vivo in two- or three-dimensional endothelial cell cultures, and expression levels were upregulated by cell density. RPTPmu was detected in few other cells: bronchial and biliary epithelia and cardiocytes (intercalated discs). Our results identify RPTPmu as a new marker of endothelial cell heterogeneity and suggest a possible role in endothelial-specific functions, involving cell-cell contact. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094839     DOI: 10.1006/excr.1999.4428

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Localisation of high acid phosphotyrosine phosphatase activity in afferent arterioles and glomeruli of human kidney.

Authors:  Seppo Partanen
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

Review 2.  Tyrosine phosphorylation and endothelial cell barrier regulation.

Authors:  Alexander D Verin
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 3.  Endothelial cell heterogeneity and atherosclerosis.

Authors:  William C Aird
Journal:  Curr Atheroscler Rep       Date:  2006-01       Impact factor: 5.113

4.  Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells.

Authors:  Gregory M Nelson; Timothy P Padera; Igor Garkavtsev; Toshi Shioda; Rakesh K Jain
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

Review 5.  Deciphering the functional role of endothelial junctions by using in vivo models.

Authors:  Daniel Nyqvist; Costanza Giampietro; Elisabetta Dejana
Journal:  EMBO Rep       Date:  2008-07-04       Impact factor: 8.807

6.  A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu.

Authors:  Susan M Burden-Gulley; Theresa J Gates; Adam M Burgoyne; Jennifer L Cutter; David T Lodowski; Shenandoah Robinson; Andrew E Sloan; Robert H Miller; James P Basilion; Susann M Brady-Kalnay
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

7.  Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia.

Authors:  Xiu Fen Sui; Timothy D Kiser; Sang Won Hyun; Daniel J Angelini; Robert L Del Vecchio; Bradford A Young; Jeffrey D Hasday; Lewis H Romer; Antonino Passaniti; Nicholas K Tonks; Simeon E Goldblum
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 8.  Interferon alpha as a primary pathogenic factor in human lupus.

Authors:  Timothy B Niewold
Journal:  J Interferon Cytokine Res       Date:  2011-09-16       Impact factor: 2.607

9.  A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development.

Authors:  Takamune Takahashi; Keiko Takahashi; Patricia L St John; Paul A Fleming; Takuya Tomemori; Toshio Watanabe; Dale R Abrahamson; Christopher J Drake; Takuji Shirasawa; Thomas O Daniel
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

10.  Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion.

Authors:  Alexandru Radu Aricescu; Wai-Ching Hon; Christian Siebold; Weixian Lu; Philip Anton van der Merwe; Edith Yvonne Jones
Journal:  EMBO J       Date:  2006-02-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.